Is “early intervention” in bipolar disorder what it claims to be?

Bipolar Disorders

Volumn 19, Issue 8, 2017, Pages 627-636

  Malhi, Gin S ^a,b,c   Morris, Grace ^a,b,c   Hamilton, Amber ^a,b,c   Outhred, Tim ^a,b,c   Mannie, Zola ^a,c  

^a St George Hospital and Community Health Service   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

bipolar disorder; bipolar prodrome; clinical; diagnosis; early intervention; interventions; mood disorders; prevention; staging; treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; MOOD STABILIZER; PLACEBO; VALPROIC ACID;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY; DISEASE SEVERITY; EARLY INTERVENTION; HUMAN; ILLNESS TRAJECTORY; MAJOR DEPRESSION; MONOTHERAPY; ONSET AGE; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; REVIEW; STAGING; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; SUICIDE;

BIPOLAR DISORDER; EARLY MEDICAL INTERVENTION; HUMANS; QUALITY OF LIFE; SUICIDE;

EID: 85038935496     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12576     Document Type: Review

References (93)

1. Passos I, Mwangi B, Vieta E, Berk M, Kapczinski F. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand. 2016;134:91-103.
2. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31:281-294.
3. Howes OD, Falkenberg I. Early detection and intervention in bipolar affective disorder: targeting the development of the disorder. Current Psychiatry Rep. 2011;13:493-499.
4. Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13:87-98.
5. Post RM, Leverich GS, Kupka RW, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71:864-872.
6. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60:261-269.
7. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530-537.
8. Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241-251.
9. Berk M, Dodd S, Malhi GS. “Bipolar missed states”: the diagnosis and clinical salience of bipolar mixed states. Aust NZJ Psychiatry. 2005;39:215-221.
10. Malhi GS. Diagnosis of bipolar disorder: who is in a mixed state? The Lancet. 2013;381:1599.
11. Fagiolini A, Coluccia A, Maina G, et al. Diagnosis, epidemiology and management of mixed states in bipolar disorder. CNS Drugs. 2015;29:725-740.
12. Malhi GS, Byrow Y, Fritz K. Mixed mood states: time to adopt a 3D perspective? Aust N Z J Psychiatry. 2015;50:613-615.
13. Malhi GS, Lampe L, Coulston CM, et al. Mixed state discrimination: a DSM problem that won׳ t go away? J Affect Disord. 2014;158:8-10.
14. Di Florio A, Craddock N, Van den Bree M. Alcohol misuse in bipolar disorder. A systematic review and meta-analysis of comorbidity rates. Eur Psychiatry. 2014;29:117-124.
15. Strakowski SM, DelBello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiat. 2000;48:477-485.
16. Malhi GS, Berk M, Morris G, et al. Mixed mood: the not so united states? Bipolar Disord. 2017;19:242-245.
17. Malhi GS, Byrow Y, Fritz K,et al. Does irritability determine mood depending on age?. Aust N Z J Psychiatry. 2017;51:215-216.
18. Cahill CM, Green MJ, Jairam R, Malhi GS. Bipolar disorder in children and adolescents: obstacles to early diagnosis and future directions. Early Intervention Psychiatry. 2007;1:138-149.
19. Shaw JA, Egeland JA, Endicott J, Allen CR, Hostetter AM. A 10-year prospective study of prodromal patterns for bipolar disorder among Amish youth. J Am Acad Child Adolesc Psychiatry. 2005;44:1104-1111.
20. Malhi GS, Bargh DM, Coulston CM, Das P, Berk M. Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention. Bipolar Disord. 2014;16:455-470.
21. Howes OD, Lim S, Theologos G, Yung AR, Goodwin GM, McGuire P. A comprehensive review and model of putative prodromal features of bipolar affective disorder. Psychol Med. 2011;41:1567-1577.
22. Correll CU, Penzner JB, Lencz T, et al. Early identification and high-risk strategies for bipolar disorder. Bipolar Disord. 2007;9:324-338.
23. Bechdolf A, Ratheesh A, Wood SJ, et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des. 2012;18:358-375.
24. Ratheesh A, Davey C, Hetrick S, et al. A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder. Acta Psychiatr Scand. 2017;135:273-284.
25. Correll CU, Hauser M, Penzner JB, et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord. 2014;16:478-492.
26. Berk M, Hallam K, Malhi GS, et al. Evidence and implications for early intervention in bipolar disorder. J Mental Health. 2010;19:113-126.
27. Post RM, Fleming J, Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res. 2012;46:561-573.
28. Alloy LB, Abramson LY, Urosevic S, Walshaw PD, Nusslock R, Neeren AM. The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors. Clin Psychol Rev. 2005;25:1043-1075.
29. Faraone SV, Glatt SJ, Tsuang MT. The genetics of pediatric-onset bipolar disorder. Biol Psychiat. 2003;53:970-977.
30. Smoller JW, Finn CT, eds. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003;123:48-58.
31. Malhi GS, Moore J, McGuffin P. The genetics of major depressive disorder. Current Psychiatry Rep. 2000;2:165-169.
32. Post R, Leverich G. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol. 2006;18:1181-1211.
33. Scott J, Meyer TD. Prospects for early intervention in bipolar disorders. Early Intervention Psychiatry. 2007;1:111-113.
34. Conus P, Macneil C, McGorry PD. Public health significance of bipolar disorder: implications for early intervention and prevention. Bipolar Disord. 2014;16:548-556.
35. Ratheesh A, Cotton SM, Davey CG, et al. Ethical considerations in preventive interventions for bipolar disorder. Early Intervention Psychiatry. 2017;11:104-112.
36. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156:1264-1266.
37. McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust. 2007;187(7 Suppl):S40-S42.
38. Passos IC, Kapczinski F. Should bipolar disorder treatment be modified depending on staging? Expert Review of Neurotherapeutics. 2017;17:93-95.
39. Berk M, Conus P, Lucas N, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9:671-678.
40. Kapczinski F, Dias VV, Kauer-Sant'Anna M, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 2009;9:957-966.
41. Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res. 2010;18:256-271.
42. Duffy A, Jones S, Goodday S, Bentall R. Candidate risks indicators for bipolar disorder: early intervention opportunities in high-risk youth. Int J Neuropsychopharmacol 2016;19:1-10.
43. McNamara RK, Nandagopal JJ, Strakowski SM, DelBello MP. Preventative strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs. 2010;24:983-996.
44. Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2012;82:20-34.
45. Fava GA, Kellner R. Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand. 1993;87:225-230.
46. Duffy A, Alda M, Crawford L, Milin R, Grof P. The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar parents. Bipolar Disord. 2007;9:828-838.
47. Duffy A. The early natural history of bipolar disorder: what we have learned from longitudinal high-risk research. Canadian J Psychiatry. 2010;55:477-485.
48. Duffy A. Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence. Canadian J Psychiatry. 2014;59:659-666.
49. Berk M, Berk L, Dodd S, et al. Stage managing bipolar disorder. Bipolar Disord. 2014;16:471-477.
50. Brietzke E, Mansur RB, Soczynska JK, Kapczinski F, Bressan RA, McIntyre RS. Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. J Affect Disord. 2012;140:82-91.
51. Rosa AR, Magalhaes PV, Czepielewski L, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75:e450-e456.
52. Reinares M, Papachristou E, Harvey P, et al. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord. 2013;144:65-71.
53. Macneil CA, Hallam K, Conus P, Henry L, Kader L, Berk M. Are we missing opportunities for early intervention in bipolar disorder? Expert Rev Neurother. 2012;12:5-7.
54. Macneil CA, Hasty MK, Berk M, et al. Psychological needs of adolescents in the early phase of bipolar disorder: implications for early intervention. Early Intervention Psychiatry. 2011;5:100-107.
55. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40:616-622.
56. Miklowitz DJ, Schneck CD, Singh MK, et al. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry. 2013;52:121-131.
57. Miklowitz DJ, Chang KD, Taylor DO, et al. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011;13:67-75.
58. Goldstein TR, Fersch-Podrat R, Axelson DA, et al. Early intervention for adolescents at high risk for the development of bipolar disorder: pilot study of Interpersonal and Social Rhythm Therapy (IPSRT). Psychotherapy. 2014;51:180-189.
59. Miklowitz DJ, Schneck CD, Walshaw PD, et al. Early intervention for youth at high risk for bipolar disorder: a multisite randomized trial of family-focused treatment. Early Intervention Psychiatry 2017. http://doi.org/10/1111/eip.12463.
60. Passos IC, Jansen K, Kapczinski F. Developmental staging models in bipolar disorder. Int J Bipolar Disord. 2015;3:16.
61. Duffy A, Malhi GS, Grof P. Do the trajectories of bipolar disorder and schizophrenia follow a universal staging model? Canadian J Psychiatry. 2017;62:115-122.
62. Conus P, Ward J, Hallam KT, et al. The proximal prodrome to first episode mania–a new target for early intervention. Bipolar Disord. 2008;10:555-565.
63. Tijssen MJ, van Os J, Wittchen HU, et al. Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study. Br J Psychiatry. 2010;196:102-108.
64. Beesdo K, Höfler M, Leibenluft E, Lieb R, Bauer M, Pfennig A. Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life. Bipolar Disord. 2009;11:637-649.
65. Duffy A, Alda M, Hajek T, Grof P. Early course of bipolar disorder in high-risk offspring: prospective study. Br J Psychiatry. 2009;195:457-458.
66. Hafeman DM, Merranko J, Axelson D, et al. Toward the definition of a bipolar prodrome: dimensional predictors of bipolar spectrum disorders in at-risk youths. Am J Psychiatry. 2016;173:695-704.
67. Hillegers MH, Reichart CG, Wals M, Verhulst FC, Ormel J, Nolen WA. Five-year prospective outcome of psychopathology in the adolescent offspring of bipolar parents. Bipolar Disord. 2005;7:344-350.
68. Egeland JA, Shaw JA, Endicott J, et al. Prospective study of prodromal features for bipolarity in well Amish children. J Am Acad Child Adolesc Psychiatry. 2003;42:786-796.
69. Egeland JA, Endicott J, Hostetter AM, Allen CR, Pauls DL, Shaw JA. A 16-year prospective study of prodromal features prior to BPI onset in well Amish children. J Affect Disord. 2012;142:186-192.
70. Thompson KN, Conus PO, Ward JL, et al. The initial prodrome to bipolar affective disorder: prospective case studies. J Affect Disord. 2003;77:79-85.
71. Alloy LB, Bender RE, Whitehouse WG, et al. High Behavioral Approach System (BAS) sensitivity, reward responsiveness, and goal-striving predict first onset of bipolar spectrum disorders: a prospective behavioral high-risk design. J Abnorm Psychol. 2012;121:339-351.
72. Van Meter AR, Burke C, Youngstrom EA, Faedda GL, Correll CU. The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episodes. J Am Acad Child Adolesc Psychiatry. 2016;55:543-555.
73. Pavuluri MN. Effects of early intervention on the course of bipolar disorder: theories and realities. Current Psychiatry Rep. 2010;12:490-498.
74. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49:1087-1206.
75. DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. The Journal of clinical psychiatry. 2007;68:789-795.
76. Geller B, Cooper TB, Zimerman B, et al. Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study. J Affect Disord. 1998;51:165-175.
77. Chang KD, Dienes K, Blasey C, Adleman N, Ketter T, Steiner H. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry. 2003;64:936-942.
78. Findling RL, Frazier TW, Youngstrom EA, et al. Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry. 2007;68:781-788.
79. Lambert M, Niehaus V, Correll C. Pharmacotherapy in children and adolescents at clinical-high risk for psychosis and bipolar disorder. Pharmacopsychiatry 2016;49:229-244.
80. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:713-720.
81. Kowatch RA, Fristad M, Birmaher B, et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:213-235.
82. Wykes T, Evans J, Paton C, et al. What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication Psychol Med 2017;47:2369-2378.
83. Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2011;21:517-535.
84. Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. Newer generation antidepressants for depressive disorders in children and adolescents. BJPsych Advances. 2017;23:74.
85. Blakemore SJ, Choudhury S. Development of the adolescent brain: implications for executive function and social cognition. J Child Psychol Psychiatry. 2006;47:296-312.
86. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007;64:1032-1039.
87. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry. 2006;63:679-685.
88. Olfson M, Marcus SC, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry. 2002;41:514-521.
89. John A, Marchant A, Fone D, et al. Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study. Psychol Med. 2016;46:3315-3327.
90. Goldstein MJ, Miklowitz DJ. Family intervention for persons with bipolar disorder. New Dir Ment Health Serv. 1994;1994:23-35.
91. Padmos RC, Hillegers MH, Knijff EM, et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008;65:395-407.
92. Mesman E, Nolen WA, Reichart CG, Wals M, Hillegers MH. The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry. 2013;170:542-549.
93. Bechdolf A, Nelson B, Cotton SM, et al. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J Affect Disord. 2010;127:316-320.